Hartford Business Journal

April 27, 2015

Issue link: https://nebusinessmedia.uberflip.com/i/500382

Contents of this Issue

Navigation

Page 21 of 27

22 Hartford Business Journal • April 27, 2015 www.HartfordBusiness.com Stories Information News Trends Ideas Meet our editorial team, and network with your neighbors! On t he R o a d On t he R o a d O n t h e R o a d Take the lead in your region, and join your business community by attending a networking reception with local business owners and executives. e HBJ hosts receptions in distinct regions of Greater Hartford in order to bring together each region's business community for networking and to exchange ideas. Here's your chance to meet the Hartford Business Journal Editorial Team, share your story ideas, and connect with professionals from around the region. Complimentary hors d'oeuvres and a cash bar will be provided. Register for this FREE event online by visiting www.HartfordBusiness.com and clicking "Our Events." Or contact Amy Orsini at 860.236.9998 ext. 134 or email aorsini@HartfordBusiness.com In Print. Online. In Person. www.HartfordBusiness.com Delivering Business. Hartford Date: May 20, 2015 • Time: 5:00pm-6:30pm Location: The Hartford Club 46 Prospect Street, Hartford • Cost: Free Greg Bordonaro, Editor Brad Kane, Managing Editor Gregory Seay, News Editor Matt Pilon, Digital Producer Event Sponsor: CORPORATE PROFILE Alexion 352 Knotter Drive, Cheshire, CT 06410 | www.alexionpharm.com Alexion Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapeutic products. It's top selling drug is Soliris, which treats a rare, life-threatning blood disorder that destroys red blood cells. Top Executive: David Hallal, CEO FACT BOX Industry: Biotechnology 1Q 2015 Revenue: $600.3M 1Q 2015 Net Income: $91.3M Quarterly Profit Change: ($68M) Cash: $916.8M Employees: 2,273 Competitors: Amgen Inc. Baxter International Inc. Genzyme Corp. TOP INSTITUTIONAL INVESTORS Holder Shares % Stake Vanguard Group Inc. 10,660,348 5.34 State Street Corp. 8,562,102 4.29 JP Morgan Chase & Co. 6,543,820 3.28 STOCK WATCH (AS OF NOON APRIL 23) Ticker Symbol: ALXN Stock Price: $182.7 Market Cap: $36.9B 52 Week Range Price: $147.81 – $203.30 Outstanding Shares: 202.15M CORPORATE SUITE (2014) Stock Non-equity Executive Title Salary Bonus Awards Incentive Total Leonard Bell Chairman/CEO $1,280,000 $0 $8,165,578 $2,028,000 $20,570,703 David Hallal COO $696,052 $0 $3,268,430 $792,000 $7,514,608 Stephen P. Squinto EVP/Ch. Global $635,000 $75,000 $3,711,397 $445,000 $9,963,844 Operations Officer

Articles in this issue

Links on this page

Archives of this issue

view archives of Hartford Business Journal - April 27, 2015